EQH vs JXN: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: JXN is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. EQH and JXN share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined EQH and JXN exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Equitable Holdings runs three connected businesses. Retirement is the biggest: individual and group annuities and retirement products, about $189 billion of assets at mid-2026, sold heavily through Equitable Advisors, a network of roughly 4,600 licensed financial professionals that also feeds a $141 billion wealth management arm. Asset Management is its roughly 68% ownership of AllianceBernstein, the active manager that ended the second quarter of 2026 with $905 billion of assets under management and a $91 billion private markets platform that Equitable itself has seeded with $25 billion of general account capital. What used to be a large life insurance operation is now mostly ceded: in July 2025 Equitable closed a deal with RGA reinsuring 75% of its in-force individual life block, about $18 billion of general account and $14 billion of separate account reserves, which released over $2 billion of value and pushed the company further toward fee and spread income. The business traces back to 1859 and reached public markets through AXA's 2018 IPO.

Full EQH guide

Jackson Financial (NYSE: JXN) is one of the largest sellers of annuities in the United States, focused on retirement-income products such as variable annuities, registered index-linked annuities (RILAs), and fixed and fixed index annuities distributed through independent advisors and broker-dealers. The company became a standalone public company in 2021 after separating from the UK's Prudential plc, and its core business is collecting premiums, managing the associated market and longevity risk (partly through hedging and reinsurance), and paying out retirement income over time.

Full JXN guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• EQH drivers: The Corebridge merger and the new parent company; Retirement flows and the annuity franchise.
• JXN drivers: Record annuity sales momentum; Aggressive capital returns.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The merger is the near-term binary. For JXN, gAAP earnings are highly volatile because of market risk benefit accounting, hedging outcomes, and reinsured business, and the company reported a small GAAP net loss to common shareholders in 2025 even as operating earnings rose.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick EQH if you believe its drivers more; JXN if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the EQH and JXN guides.

EQH. At about $51.87 the stock sits near seven to eight times its second quarter operating earnings annualized, the kind of multiple annuity writers usually carry because their GAAP results swing with hedging rather than with the business. The gap between $488 million of operating profit and a $453 million net loss is almost entirely non-economic, driven by fair value changes in market risk benefits and the derivatives used to hedge them. Assets under management and administration hit a record $1.175 trillion, up 10% year over year. Every per-share figure here is pre-merger: at close each share converts into 1.55516 shares of the new parent, so price and EPS both rebase.

JXN. JXN trades below book value with a low forward earnings multiple, a pattern common for annuity insurers whose GAAP results swing with markets and hedging. Adjusted operating earnings grew in 2025 and into Q1 2026 even though GAAP net income to common shareholders was a small loss for full-year 2025. The valuation and yield largely reflect the company's cash generation and capital-return program rather than smooth reported profit.

Headline figures (approximate, August 2026): EQH shows share price / market cap ~$51.87, ~$14.1B, revenue (ttm) ~$10.6B, non-gaap operating eps (q2 2026) ~$1.70 (~$1.75 ex-notable items, up ~24% y/y), gaap result (q2 2026) net loss of ~$453M, or ~$1.68 per share; JXN shows market cap ~$7.8B, 2025 adjusted operating eps ~$22.67, q1 2026 adjusted operating eps (ex notable items) ~$5.94, annual dividend / yield ~$3.60 (~3.3%).

EQH and JXN are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined EQH and JXN exposure against your real portfolio. It is not an investment adviser.